Prudential Financial’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-45,200
| Closed | -$43.4K | – | 2737 |
|
|
2023
Q2 | $43.4K | Buy |
+45,200
| New | +$44.7K | ﹤0.01% | 2547 |
|
|
2022
Q2 | – | Sell |
-11,121
| Closed | -$14K | – | 2780 |
|
|
2022
Q1 | $14K | Sell |
11,121
-158,873
| -93% | -$146K | ﹤0.01% | 2589 |
|
|
2021
Q4 | $216K | Sell |
169,994
-1,095
| -0.6% | -$1.96K | ﹤0.01% | 2521 |
|
|
2021
Q3 | $373K | Buy |
171,089
+1,720
| +1% | +$4.7K | ﹤0.01% | 2248 |
|
|
2021
Q2 | $635K | Buy |
169,369
+6,518
| +4% | +$22.7K | ﹤0.01% | 2049 |
|
|
2021
Q1 | $531K | Sell |
162,851
-1,120
| -0.7% | -$4.01K | ﹤0.01% | 2112 |
|
|
2020
Q4 | $559K | Buy |
163,971
+690
| +0.4% | +$2.84K | ﹤0.01% | 2016 |
|
|
2020
Q3 | $666K | Buy |
163,281
+29,410
| +22% | +$112K | ﹤0.01% | 1838 |
|
|
2020
Q2 | $452K | Sell |
133,871
-79,680
| -37% | -$232K | ﹤0.01% | 1962 |
|
|
2020
Q1 | $498K | Buy |
213,551
+16,834
| +9% | +$46.1K | ﹤0.01% | 1913 |
|
|
2019
Q4 | $716K | Sell |
196,717
-18,750
| -9% | -$151K | ﹤0.01% | 1963 |
|
|
2019
Q3 | $1.79M | Buy |
215,467
+5,874
| +3% | +$47.5K | ﹤0.01% | 1640 |
|
|
2019
Q2 | $1.8M | Buy |
209,593
+40,070
| +24% | +$358K | ﹤0.01% | 1642 |
|
|
2019
Q1 | $1.81M | Buy |
169,523
+4,067
| +2% | +$43.6K | ﹤0.01% | 1647 |
|
|
2018
Q4 | $1.45M | Sell |
165,456
-9,405
| -5% | -$120K | ﹤0.01% | 1672 |
|
|
2018
Q3 | $2.94M | Sell |
174,861
-135,140
| -44% | -$2.92M | ﹤0.01% | 1440 |
|
|
2018
Q2 | $6.5M | Buy |
310,001
+157,960
| +104% | +$2.93M | 0.01% | 1112 |
|
|
2018
Q1 | $2.45M | Buy |
152,041
+5,050
| +3% | +$100K | ﹤0.01% | 1495 |
|
|
2017
Q4 | $2.79M | Buy |
146,991
+21,850
| +17% | +$396K | ﹤0.01% | 1435 |
|
|
2017
Q3 | $1.76M | Buy |
125,141
+8,745
| +8% | +$79.1K | ﹤0.01% | 1636 |
|
|
2017
Q2 | $867K | Sell |
116,396
-263,100
| -69% | -$1.72M | ﹤0.01% | 1888 |
|
|
2017
Q1 | $2.47M | Buy |
379,496
+191,180
| +102% | +$1.07M | ﹤0.01% | 1471 |
|
|
2016
Q4 | $834K | Sell |
188,316
-191,600
| -50% | -$804K | ﹤0.01% | 1897 |
|
|
2016
Q3 | $1.77M | Sell |
379,916
-60,950
| -14% | -$361K | ﹤0.01% | 1569 |
|
|
2016
Q2 | $2.9M | Buy |
440,866
+301,100
| +215% | +$2.13M | ﹤0.01% | 1377 |
|
|
2016
Q1 | $889K | Buy |
139,766
+4,100
| +3% | +$21K | ﹤0.01% | 1851 |
|
|
2015
Q4 | $818K | Buy |
135,666
+1,100
| +0.8% | +$6.29K | ﹤0.01% | 1841 |
|
|
2015
Q3 | $805K | Buy |
134,566
+2,400
| +2% | +$16.7K | ﹤0.01% | 1825 |
|
|
2015
Q2 | $904K | Buy |
132,166
+8,400
| +7% | +$53.3K | ﹤0.01% | 1842 |
|
|
2015
Q1 | $751K | Sell |
123,766
-3,600
| -3% | -$24K | ﹤0.01% | 1904 |
|
|
2014
Q4 | $883K | Buy |
127,366
+7,600
| +6% | +$55.9K | ﹤0.01% | 1777 |
|
|
2014
Q3 | $975K | Sell |
119,766
-5,964
| -5% | -$46.7K | ﹤0.01% | 1734 |
|
|
2014
Q2 | $1.02M | Buy |
125,730
+6,164
| +5% | +$46.8K | ﹤0.01% | 1802 |
|
|
2014
Q1 | $937K | Buy |
119,566
+900
| +0.8% | +$7.62K | ﹤0.01% | 1771 |
|
|
2013
Q4 | $1.05M | Buy |
118,666
+700
| +0.6% | +$6.25K | ﹤0.01% | 1737 |
|
|
2013
Q3 | $990K | Buy |
117,966
+2,900
| +3% | +$23.5K | ﹤0.01% | 1739 |
|
|
2013
Q2 | $858K | Buy |
+115,066
| New | +$883K | ﹤0.01% | 1770 |
|
Prudential Financial's SPPI Position: Q3 2023 in Review
Prudential Financial sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q3 2023, closing a stake of 45,200 shares — an estimated $43.4K sold.
Prudential Financial first reported a position in SPPI in Q2 2013 and held it in 37 quarters. The position peaked at $6.5M in Q2 2018. 0 funds tracked by Wall St. Rank hold SPPI as of Q3 2023.
- Prudential Financial reported no remaining Spectrum Pharmaceuticals Inc position as of Q3 2023 after selling out during the quarter.
- Prudential Financial sold 45,200 Spectrum Pharmaceuticals Inc shares in Q3 2023, an estimated $43.4K.
- Prudential Financial first reported a position in Spectrum Pharmaceuticals Inc in Q2 2013 and held it in 37 quarters.
- Prudential Financial's Spectrum Pharmaceuticals Inc position peaked at $6.5M in Q2 2018.
- 0 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q3 2023.
Based on Prudential Financial's 13F filing for Q3 2023, filed 13 Nov 2023.